Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-10-02
Original market date: See footnote 1
2010-10-22
Product name:
RECONCILE
DIN:
02307960
Product Monograph/Veterinary Labelling:
Date:
2018-07-24
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PEGASUS LABORATORIES INC
8809 Ely Road
Pensacola
Florida
United States
32514
Class:
Veterinary
Species:
Dogs
Dosage form(s):
Tablet (Chewable)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Not Applicable
Active ingredient group (AIG) number:See footnote5
0116847006
| Active ingredient(s) | Strength |
|---|---|
| FLUOXETINE (FLUOXETINE HYDROCHLORIDE) | 16 MG |